TY - JOUR
T1 - Cerebral Intraventricular 6-Hydroxydopamine Prevents Vascular Changes in the Mineralocorticoid Hypertensive Rat
AU - Mecca, T. E.
AU - Lamb, F. S.
AU - Hall, J. L.
AU - Webb, R. C.
N1 - Funding Information:
These studies were supported by grants from the National Institutes of Health (HL-27020, HL-18575). Dr. Mecca is a recipient of a Public Health Service Award from the National Institutes of Health (HL-06566). Dr. Webb is a recipient of a Research Career Development Award from the National Institutes of Health (HL-00813).
PY - 1985/6
Y1 - 1985/6
N2 - The effect of cerebral intraventricular administration of 6-hydroxydopamine (6-OHDA) on blood pressure and vascular smooth muscle responsiveness in deoxycorticosterone acetate (DOCA)-treated rats was assessed. Rats treated with 6-OHDA and DOCA had significantly lower systolic blood pressures (142 ± 8 mm Hg) than rats treated with DOCA alone (185 ± 5 mm Hg). After 5 weeks of DOCA treatment, femoral arteries and aortae were excised from these rats, cut helically into strips, and placed in a muscle bath to record isometric force. Dose-response curves to serotonin were shifted to the left in femoral arteries from DOCA-treated rats compared to both control and 6-OHDA-DOCA-treated rats (ED50: DOCA = 6.8 × 10−8 M, control = 27.9 × 10−8 M, 6-OHDA-DOCA = 13.4 × 10−8 M). Arachidonic acid, the prostaglandin precursor, produced greater maximal contractions in femoral artery strips of DOCA-treated rats (358 ± 56 mg) than in those from controls (115 ± 31 mg). The maximal response to arachidonic acid in arteries from 6-OHDA-DOCA rats (203 ± 78 mg) was not different from control values. Ouabain produced a greater maximal response in aortic strips from DOCA rats (658 ± 165 mg) compared to those from control (196 ± 72 mg) or 6-OHDA-DOCA (309 ± 87 mg) rats. We conclude that increased vascular responsiveness to serotonin, arachidonic acid, and ouabain in DOCA hypertensive rats is secondary to a central action of the mineralocorticoid.
AB - The effect of cerebral intraventricular administration of 6-hydroxydopamine (6-OHDA) on blood pressure and vascular smooth muscle responsiveness in deoxycorticosterone acetate (DOCA)-treated rats was assessed. Rats treated with 6-OHDA and DOCA had significantly lower systolic blood pressures (142 ± 8 mm Hg) than rats treated with DOCA alone (185 ± 5 mm Hg). After 5 weeks of DOCA treatment, femoral arteries and aortae were excised from these rats, cut helically into strips, and placed in a muscle bath to record isometric force. Dose-response curves to serotonin were shifted to the left in femoral arteries from DOCA-treated rats compared to both control and 6-OHDA-DOCA-treated rats (ED50: DOCA = 6.8 × 10−8 M, control = 27.9 × 10−8 M, 6-OHDA-DOCA = 13.4 × 10−8 M). Arachidonic acid, the prostaglandin precursor, produced greater maximal contractions in femoral artery strips of DOCA-treated rats (358 ± 56 mg) than in those from controls (115 ± 31 mg). The maximal response to arachidonic acid in arteries from 6-OHDA-DOCA rats (203 ± 78 mg) was not different from control values. Ouabain produced a greater maximal response in aortic strips from DOCA rats (658 ± 165 mg) compared to those from control (196 ± 72 mg) or 6-OHDA-DOCA (309 ± 87 mg) rats. We conclude that increased vascular responsiveness to serotonin, arachidonic acid, and ouabain in DOCA hypertensive rats is secondary to a central action of the mineralocorticoid.
UR - http://www.scopus.com/inward/record.url?scp=0022255256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022255256&partnerID=8YFLogxK
U2 - 10.3181/00379727-179-42094
DO - 10.3181/00379727-179-42094
M3 - Article
C2 - 3921975
AN - SCOPUS:0022255256
SN - 1535-3702
VL - 179
SP - 248
EP - 253
JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)
JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)
IS - 2
ER -